Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC)
暂无分享,去创建一个
K. Miller | M. Schostak | U. Reichelt | H. Krause | D. Baumunk | H. Cash | S. Weikert | J. Ebbing | Jannis Hildebrandt
[1] M. Merino,et al. Misdiagnosis of clear cell renal cell carcinoma , 2011, Nature Reviews Urology.
[2] Joachim Selbig,et al. Metabolic profiling reveals key metabolic features of renal cell carcinoma , 2009, Journal of cellular and molecular medicine.
[3] H. Deeg,et al. Identification of DJ-1/PARK-7 as a determinant of stroma-dependent and TNF-alpha-induced apoptosis in MDS using mass spectrometry and phosphopeptide analysis. , 2010, Blood.
[4] R. Sun,et al. Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo , 2010, Breast Cancer Research and Treatment.
[5] Divya Pathania,et al. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism. , 2009, Advanced drug delivery reviews.
[6] B. Hallberg,et al. The PTEN regulator DJ‐1 is associated with hTERT expression in clear cell renal cell carcinoma , 2009, International journal of cancer.
[7] David S. Park,et al. DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses , 2009, Proceedings of the National Academy of Sciences.
[8] J. Mackey,et al. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer , 2008, British Journal of Cancer.
[9] Robert A. Harris,et al. Pyruvate Dehydrogenase Complex Activity Controls Metabolic and Malignant Phenotype in Cancer Cells* , 2008, Journal of Biological Chemistry.
[10] A. Giatromanolaki,et al. PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer , 2008, British Journal of Cancer.
[11] G. Semenza,et al. Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1 , 2007, Molecular and Cellular Biology.
[12] A. Giatromanolaki,et al. Lung cancer: An organized cellular and metabolic domain , 2007 .
[13] Yaochen Li,et al. Mutant TNF-α negatively regulates human breast cancer stem cells from MCF7 in vitro , 2007, Cancer biology & therapy.
[14] P. Sutphin,et al. Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy , 2007, Proceedings of the National Academy of Sciences.
[15] T. Mak,et al. Metabolic Targeting as an Anticancer Strategy: Dawn of a New Era? , 2007, Science's STKE.
[16] A. Giatromanolaki,et al. Lung cancer: a comparative study of metabolism related protein expression in cancer cells and tumor associated stroma. , 2007, Cancer biology & therapy.
[17] C. Dang. The interplay between MYC and HIF in the Warburg effect. , 2007, Ernst Schering Foundation symposium proceedings.
[18] Sébastien Bonnet,et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. , 2007, Cancer cell.
[19] G. Kristiansen,et al. In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR , 2007, BMC Molecular Biology.
[20] Ken Garber,et al. Energy Deregulation: Licensing Tumors to Grow , 2006, Science.
[21] N. Denko,et al. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. , 2006, Cell metabolism.
[22] A. Harris,et al. Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma. , 2005, Neoplasia.
[23] Ronald Simon,et al. Influence of slide aging on results of translational research studies using immunohistochemistry , 2004, Modern Pathology.
[24] M. Patel,et al. Site Specificity of Four Pyruvate Dehydrogenase Kinase Isoenzymes toward the Three Phosphorylation Sites of Human Pyruvate Dehydrogenase* , 2001, The Journal of Biological Chemistry.
[25] H. Moch,et al. Tissue microarrays for gene amplification surveys in many different tumor types. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.